Edition:
United Kingdom

Precision Therapeutics Inc (AIPT.OQ)

AIPT.OQ on NASDAQ Stock Exchange Capital Market

0.99USD
18 Jan 2019
Change (% chg)

$0.00 (+0.42%)
Prev Close
$0.98
Open
$0.98
Day's High
$1.00
Day's Low
$0.94
Volume
32,494
Avg. Vol
11,087
52-wk High
$1.57
52-wk Low
$0.60

Latest Key Developments (Source: Significant Developments)

Precision Therapeutics Inc files prospectus related to offering from time to time of up to 4.1 million co's shares by selling stockholders - SEC Filing
Wednesday, 19 Dec 2018 

Dec 19 (Reuters) - Precision Therapeutics Inc ::PRECISION THERAPEUTICS INC FILES PROSPECTUS RELATED TO OFFERING FROM TIME TO TIME OF UP TO 4.1 MILLION CO'S SHARES BY SELLING STOCKHOLDERS - SEC FILING.  Full Article

Precision Therapeutics Signs Merger Agreement With Helomics Holding Corp
Friday, 29 Jun 2018 

June 28 (Reuters) - Precision Therapeutics Inc ::PRECISION THERAPEUTICS SIGNS DEFINITIVE MERGER AGREEMENT WITH HELOMICS HOLDING CORPORATION.PRECISION THERAPEUTICS SIGNS DEFINITIVE MERGER AGREEMENT WITH HELOMICS HOLDING CORPORATION.PRECISION WILL INCREASE ITS EQUITY STAKE IN HELOMICS FROM 25% TO 100%.PRECISION THERAPEUTICS - SHARES OF HELOMICS STOCK NOT HELD BY CO TO BE CONVERTED INTO RIGHT TO RECEIVE PROPORTIONATE SHARE OF 7.5 MILLION SHARES OF CO STOCK.PRECISION THERAPEUTICS -DEAL CONDITIONED ON AT LEAST 75% OF HELOMICS' $7.6 MILLION IN NOTES EXCHANGED FOR ADDITIONAL SHARES OF CO STOCK AT $1 PER SHARE.  Full Article

Precision Therapeutics Signs Letter Of Intent To Purchase Remainder Of Helomics Corporation Shares
Monday, 23 Apr 2018 

April 23 (Reuters) - Precision Therapeutics Inc ::PRECISION THERAPEUTICS, INC. SIGNS LETTER OF INTENT TO PURCHASE REMAINDER OF HELOMICS CORPORATION SHARES.PRECISION THERAPEUTICS - UNDER TERMS OF AGREEMENT, A NEW WHOLLY OWNED UNIT OF CO WILL MERGE WITH AND INTO HELOMICS CORP.PRECISION THERAPEUTICS INC - AGREEMENT INCREASES PRECISION'S EQUITY STAKE IN HELOMICS FROM 25% TO 100%.PRECISION THERAPEUTICS- OUTSTANDING SHARES OF HELOMICS STOCK TO BE CONVERTED INTO RIGHT TO RECEIVE PROPORTIONATE SHARE OF 7.5 MILLION SHARES OF CO'S STOCK.PRECISION THERAPEUTICS INC - ALL WARRANTS OF HELOMICS' COMMON STOCK WILL BE CONVERTED INTO WARRANTS TO PURCHASE SHARES OF PRECISION COMMON STOCK.PRECISION THERAPEUTICS- HELOMICS' MANAGEMENT TEAM TO REMAIN IN RESPECTIVE LEADERSHIP POSITIONS AT HELOMICS, TO MANAGE CO'S TUMORGENESIS OPERATIONS.  Full Article

Precision Therapeutics Announces Record Streamway System Sales In The First Three Months Of 2018
Thursday, 29 Mar 2018 

March 29 (Reuters) - Precision Therapeutics Inc ::PRECISION THERAPEUTICS ANNOUNCES RECORD STREAMWAY® SYSTEM SALES IN THE FIRST THREE MONTHS OF 2018.PRECISION THERAPEUTICS INC - ‍SKYLINE MEDICAL SOLD 16 STREAMWAY SYSTEMS IN Q1 OF 2018​.PRECISION THERAPEUTICS INC - CO CONTINUES TO PROJECT A TOTAL OF 100 STREAMWAY SYSTEM SALES IN 2018​.  Full Article

Skyline Medical Changes Corporate Name To Precision Therapeutics
Thursday, 25 Jan 2018 

Jan 25 (Reuters) - Skyline Medical Inc ::SKYLINE MEDICAL ANNOUNCES CORPORATE NAME CHANGE TO PRECISION THERAPEUTICS.SKYLINE MEDICAL - CO WILL CHANGE TICKER SYMBOL ON NASDAQ TO 'AIPT'.  Full Article

Skyline Medical Says Sold Ten Streamway Systems In 2017
Wednesday, 3 Jan 2018 

Jan 3 (Reuters) - Skyline Medical Inc ::SKYLINE MEDICAL INC - COMPANY SOLD TEN STREAMWAY SYSTEMS IN 2017, FIVE OF WHICH WERE SOLD IN FOURTH FISCAL QUARTER OF 2017.SKYLINE MEDICAL INC - A FURTHER SIX STREAMWAY UNITS HAVE BEEN BOOKED FOR SALE IN JANUARY 2018.  Full Article

Skyline Medical And Helomics Expand Into Next Generation Sequencing For Personalized Medicine
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - Helomics Corp ::SKYLINE MEDICAL AND HELOMICS EXPAND INTO NEXT GENERATION SEQUENCING FOR PERSONALIZED MEDICINE.SKYLINE MEDICAL INC - EXPANDING INTO NEXT GENERATION SEQUENCING THROUGH LICENSING OF AN NGS PLATFORM MISEQDX, FROM ILLUMINA.SKYLINE MEDICAL INC - "WE FULLY EXPECT NGS PLATFORM TO DRIVE REVENUE FROM NEW PARTNERSHIPS EARLY IN 2018".  Full Article

Skyline Medical Says Acquiring Up To 25 Pct Stake In Helomics
Tuesday, 19 Dec 2017 

Dec 19 (Reuters) - Skyline Medical Inc ::SKYLINE MEDICAL ACQUIRING UP TO 25% EQUITY STAKE IN HELOMICS CORPORATION, A PRECISION DIAGNOSTICS COMPANY.SKYLINE MEDICAL - PURCHASING PREFERRED STOCK CONVERTIBLE INTO 20% OF OUTSTANDING STOCK OF HELOMICS FOR 1.1 MILLION SHARES OF NEWLY ISSUED CO'S STOCK.  Full Article

Skyline Medical Files For Resale Of Up To 1.9 Mln Shares By Selling Stockholder
Friday, 8 Dec 2017 

Dec 8 (Reuters) - Skyline Medical Inc ::SKYLINE MEDICAL INC FILES FOR RESALE OF UP TO 1.9 MILLION SHARES OF CO'S COMMON STOCK BY THE SELLING STOCKHOLDER - SEC FILING.  Full Article

Skyline Medical and Helomics Announce Joint Strategic Partnership With GLG Pharma
Tuesday, 28 Nov 2017 

Nov 28 (Reuters) - Helomics Corp ::SKYLINE MEDICAL AND HELOMICS ANNOUNCE A JOINT STRATEGIC PARTNERSHIP WITH GLG PHARMA.SKYLINE MEDICAL - ‍NEW PARTNERSHIP TO FILE FOR EUROPEAN GRANT APPLICATION TO EXPAND GLG'S AND SKYLINE-HELOMICS VENTURE'S PRODUCT OFFERING​ ACROSS EUROPE.  Full Article

No consensus analysis data available.